miR-31 may help target treatments for Crohn’s patients
Researchers have pinpointed a single molecule - microRNA-31 (miR-31) - the levels of which predict whether a patient has subtype 1 or subtype 2 of Crohn's disease...
List view / Grid view
Researchers have pinpointed a single molecule - microRNA-31 (miR-31) - the levels of which predict whether a patient has subtype 1 or subtype 2 of Crohn's disease...
A Lassa fever vaccine offers researchers a different way to test for protection, which could aid the development of more potent vaccines...
Researchers have identified that the RNA molecule nc886 begins a series of events that leads to the destruction of viruses...
Researchers have identified that MHC Class I-high, CDK1 high molecules may be at the heart of conditions including melanoma, pancreatic and colon cancers...
A bridge-like structure in oestrogen has been identified by researchers at Case Western Reserve University School of Medicine as a potential drug target...
The action of a venomous snakebite from vipers could be treated using a flavonoid called rutin, an inexpensive plant based compound...
Researchers at The Wistar Institute have developed a DNA based vaccine that has offered compete protection against the Ebola virus in preclinical trials...
Immunotherapy using 'educated' killer cells could be a potential cure for pancreatic cancer, with researchers eliminating all signs of cancer from mice...
Scientists at Scripps Research have identified the molecule in neurons responsible for tactile allodynia, a protein called PIEZO2...
Scientists may have found a sensitive time period where autism related social deficits could be reversed in tuberous sclerosis...
A micropeptide molecule that reverses structural and functional changes in the heart could be a promising target for gene therapy...
Researchers in Europe have developed a treatment that targets a tumour cell population responsible for therapy resistance and tumour relapse, giving optimism for patients with the most frequent form of cancer.
Researchers in the states have discovered a particular gene mutation that slows down sugar metabolism in the gut, indicating future treatment options for individuals with cardiometabolic and sugar-associated diseases.
UEx researchers have identified a potential biomarker for Alzheimer's disease using the CRISPR gene editing technique to analyse brain samples...
The Drug Target Review team are at Elrig Drug Discovery 2018 in the London ExCel...